Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein

I. Rinaldi; A. H. Reksodiputro; S. W.A. Jusman; A. Harahap; R. Setiabudy; S. I. Wanandi; K. Tambunan; C. Suharti

doi:10.1093/annonc/mdx664.006

Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein

I. Rinaldi, A. H. Reksodiputro, S. W.A. Jusman, A. Harahap, R. Setiabudy, S. I. Wanandi, K. Tambunan, C. Suharti

Research output: Contribution to journal › Article › peer-review

238 Citations (Scopus)

Original language	English
Pages (from-to)	x96
Journal	Annals of Oncology
Volume	28
DOIs	https://doi.org/10.1093/annonc/mdx664.006
Publication status	Published - Nov 2017

Access to Document

10.1093/annonc/mdx664.006

Cite this

Rinaldi, I., Reksodiputro, A. H., Jusman, S. W. A., Harahap, A., Setiabudy, R., Wanandi, S. I., Tambunan, K., & Suharti, C. (2017). Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein. Annals of Oncology, 28, x96. https://doi.org/10.1093/annonc/mdx664.006

@article{c58f4c29533d414b83d209f24d2d0ba2,

title = "Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein",

author = "I. Rinaldi and Reksodiputro, {A. H.} and Jusman, {S. W.A.} and A. Harahap and R. Setiabudy and Wanandi, {S. I.} and K. Tambunan and C. Suharti",

year = "2017",

month = nov,

doi = "10.1093/annonc/mdx664.006",

language = "English",

volume = "28",

pages = "x96",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Rinaldi, I, Reksodiputro, AH, Jusman, SWA , Harahap, A , Setiabudy, R , Wanandi, SI, Tambunan, K & Suharti, C 2017, 'Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein', Annals of Oncology, vol. 28, pp. x96. https://doi.org/10.1093/annonc/mdx664.006

Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein. / Rinaldi, I.; Reksodiputro, A. H.; Jusman, S. W.A. et al.
In: Annals of Oncology, Vol. 28, 11.2017, p. x96.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia

T2 - A review on P-glycoprotein

AU - Rinaldi, I.

AU - Reksodiputro, A. H.

AU - Jusman, S. W.A.

AU - Harahap, A.

AU - Setiabudy, R.

AU - Wanandi, S. I.

AU - Tambunan, K.

AU - Suharti, C.

PY - 2017/11

Y1 - 2017/11

UR - http://www.scopus.com/inward/record.url?scp=85076105775&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx664.006

DO - 10.1093/annonc/mdx664.006

M3 - Article

SN - 0923-7534

VL - 28

SP - x96

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Association between duration of hydroxyurea administration before matinib mesylate to the achievement of major molecular response (MMR) in chronic phase of chronic myelocytic leukemia: A review on P-glycoprotein

Access to Document

Other files and links

Cite this